Biodiesel: is it any safer to use?

J. Bolaji (London, United Kingdom), J. Adcock (London, United Kingdom), T. Sandström (Umeå, Sweden), I. Mudway (London, United Kingdom), A. Bloomberg (Umeå, Sweden), J. Bosson (Umeå, Sweden), T. Tetley (London, United Kingdom), M. Birrell (London, United Kingdom), M. Belvisi (Gothenburg, Sweden)

Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Bolaji (London, United Kingdom), J. Adcock (London, United Kingdom), T. Sandström (Umeå, Sweden), I. Mudway (London, United Kingdom), A. Bloomberg (Umeå, Sweden), J. Bosson (Umeå, Sweden), T. Tetley (London, United Kingdom), M. Birrell (London, United Kingdom), M. Belvisi (Gothenburg, Sweden). Biodiesel: is it any safer to use?. 1195

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biodiesel usage in Austria: Improving or deteriorating respiratory health?
Source: Annual Congress 2011 - Air pollution
Year: 2011

Positional therapy: easy and effective?
Source: Sleep and Breathing Conference 2017
Year: 2017

Who can pay for innovative medicines?
Source: Eur Respir J 2013; 41: 495-496
Year: 2013


Asthma: still a promising future?
Source: Eur Respir Rev 2014; 23: 405-407
Year: 2014


Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016


Inhaled antibiotics: a new tool?
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009


Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?
Source: Eur Respir J 2004; 23: 793-794
Year: 2004


Which equipment to choose?
Source: Annual Congress 2009 - PG16 How to organise a respiratory high dependency unit?
Year: 2009

Heated tobacco product marketing: internet platforms undermine regulations
Source: International Congress 2019 – Challenges in tobacco control and cessation
Year: 2019

Can bronchoscopy be made safer through team-based Simulation?
Source: International Congress 2018 – Medical education via the web and the internet
Year: 2018


Bedaquiline: how better to use it
Source: Eur Respir J, 50 (5) 1701670; 10.1183/13993003.01670-2017
Year: 2017



Predicting inhaler technique maintenance: An art or a science?
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016


Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018


The issues and the controversies: are we really ready for on-demand use of ICS?
Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use?
Year: 2013


Cleaning agents: how they look like and how might they cause respiratory harm?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018


Tele-medicine: a new promised land, just to save resources?
Source: Eur Respir J, 49 (5) 1700410; 10.1183/13993003.00410-2017
Year: 2017